Global framework on essential health R&D. [Lancet. 2006] - PubMed

loading

To fully tackle the gang of four, needs-driven R & D is essential. [PLoS Med. 2006]
To fully tackle the gang of four, needs-driven R & D is essential.
Torreele E, Royce C, Don R, Sevcsik AM, Croft S. PLoS Med. 2006 Jun; 3(6):e282; author reply e284. Epub 2006 Jun 27.
Mission possible. [Nature. 2007]
Mission possible.
Hopkins AL, Witty MJ, Nwaka S. Nature. 2007 Sep 13; 449(7159):166-9.
Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts. [Trop Med Int Health. 1999]
Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts.
Trouiller P, Battistella C, Pinel J, Pecoul B. Trop Med Int Health. 1999 Jun; 4(6):412-20.
Review [Tropical medicine and the pathology of poverty. New paradigms in international health policy]. [Ann Ig. 1998]
Review [Tropical medicine and the pathology of poverty. New paradigms in international health policy].
Stefanini A. Ann Ig. 1998 Sep-Dec; 10(5-6):387-93.
Review The pharmaceutical industry and health in the Third World. [Soc Sci Med. 1986]
Review The pharmaceutical industry and health in the Third World.
Taylor D. Soc Sci Med. 1986; 22(11):1141-9.

Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation. [Curr Pharmacogenomics Person M...]
Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.
Warnich L, Drögemöller BI, Pepper MS, Dandara C, Wright GE. Curr Pharmacogenomics Person Med. 2011 Sep; 9(3):191-207.
Fostering Canadian drug research and development for neglected tropical diseases. [Open Med. 2010]
Fostering Canadian drug research and development for neglected tropical diseases.
Gabriel P, Goulding R, Morgan-Jonker C, Turvey S, Nickerson J. Open Med. 2010; 4(2):e117-22. Epub 2010 May 25.
Review Drug discovery and development for neglected diseases: the DNDi model. [Drug Des Devel Ther. 2011]
Review Drug discovery and development for neglected diseases: the DNDi model.
Chatelain E, Ioset JR. Drug Des Devel Ther. 2011 Mar 16; 5:175-81. Epub 2011 Mar 16.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Global framework on essential health R&D.
Global framework on essential health R&D.
Lancet. 2006 May 13 ;367(9522):1560-1.

PubMed
Neuropathology of human immunodeficiency virus infection.
Neuropathology of human immunodeficiency virus infection.
Brain Pathol. 1991 Apr ;1(3):163-75.

PubMed
A TRPC-like non-selective cation current activated by alpha 1-adrenoceptors in r...
A TRPC-like non-selective cation current activated by alpha 1-adrenoceptors in rat mesenteric artery smooth muscle cells.
Cell Calcium. 2006 Jul ;40(1):29-40. Epub 2006 May 11 .

PubMed
The Cardiovascular Health Study: design and rationale.
The Cardiovascular Health Study: design and rationale.
Ann Epidemiol. 1991 Feb ;1(3):263-76.

PubMed
Proteomic profiling of fibroblasts reveals a modulating effect of extracellular ...
Proteomic profiling of fibroblasts reveals a modulating effect of extracellular calumenin on the organization of the actin cytoskeleton.
Proteomics. 2006 Jun ;6(12):3509-19.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed